EichorEICHOR
Location: Fukuoka Synced from ClinicalTrials.gov · August 10, 2026

Clinical studies recruiting near Fukuoka

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

Observational Study Protocol: LIVER-R
Phase N/A · AstraZeneca · NCT06252753A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
Phase 3 · Kyushu University Hospital · Eli Lilly and Company · NCT07218380Symptoms and Functions in Patients With COPD and Chronic Bronchitis Switching From CIG to THS
NA · Soejima Clinic · Philip Morris Products S.A. · NCT07108166Recombinant Factor VIIa (rFVIIa) for Hemorrhagic Stroke Trial - Part 2
Phase 3 · Kyushu Medical Center · Joseph Broderick, MD · NCT07227246This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide W
Phase 3 · National Hospital Organization Kyushu Cancer Center · Pfizer · NCT07028853Study of Trastuzumab Deruxtecan Versus Standard of Care Chemotherapy for HER2-Expressing (IHC 3+/2+) Endometrial Cancer
Phase 3 · NHO Kyushu Cancer Center · Daiichi Sankyo · NCT07022483A Study of Nemtabrutinib (MK-1026) Versus Comparator (Investigator's Choice of Ibrutinib or Acalabrutinib) in First Line
Phase 3 · Kyushu University Hospital ( Site 1914) · Merck Sharp & Dohme LLC · NCT06136559A Three-arm Randomized Phase II Study of Dostarlimab Alone or With Bevacizumab Versus Nonplatinum Chemotherapy in Recurr
Phase 2 · Yonsei University · NCT06023862This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in
Phase 3 · National Hospital Organization Kyushu Medical Center · Pfizer · NCT06758401A Study to Assess the Long-term Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder (BALSAM-3)
Phase 3 · Kuramitsu Hospital · Bristol-Myers Squibb · NCT06929273PODOMOUNT-Basket, a Study to Test Whether BI 764198 Helps Adults and Adolescents With Different Types of Kidney Disease
Phase 2 · Japanese Red Cross Fukuoka Hospital · Boehringer Ingelheim · NCT07355296A Non-Interventional Study PASS to Characterize Secondary Malignancies of Tcell Origin Following Tisagenlecleucel Therap
Phase N/A · Novartis Pharmaceuticals · NCT07378969A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have or Have Not Been Treated With Biologic Medicines
Phase 3 · Fukuoka University Hospital · Takeda · NCT06671496A 52-week Study of Rilzabrutinib Efficacy and Safety Compared to Placebo in Adults Diagnosed With IgG4-related Disease
Phase 3 · Sanofi · NCT07190196A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carbop
Phase 3 · Kyushu University Hospital · Hoffmann-La Roche · NCT06793215A Study to Evaluate the Long-term Safety and Tolerability of KarXT and KarX-EC for the Treatment of Schizophrenia and Au
Phase 3 · Karuna Therapeutics, Inc., a Bristol Myers Squibb company · NCT07424404A Study to Evaluate the Efficacy and Safety of KarXT for the Treatment of Schizophrenia in Adolescents (EMERGENT TEEN)
Phase 3 · Bristol-Myers Squibb · NCT07288567Symbiotic-GU-06: A Study to Learn About PF-08634404 Alone or In Combination With Enfortumab Vedotin in Urothelial Cancer
Phase 1/Phase 2 · National Hospital Organization Kyushu Cancer Center · Pfizer · NCT07421700Phase III Study of Ivonescimab or Bevacizumab Combined With FOLFOX in Patients With Metastatic Colorectal Cancer
Phase 3 · Clinical Study Site · Summit Therapeutics · NCT07228832LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis
Phase 2 · Fukuoka University Hospital · Eli Lilly and Company · NCT07415044A Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) as First-line Maintena
Phase 3 · National Hospital Organization Kyushu Cancer Center ( Site 2 · Merck Sharp & Dohme LLC · NCT07216703A Study to Assess the Effectiveness and Safety of IPN10200 Over Time in Adults With Moderate to Severe Wrinkle-like Line
Phase 3 · Josui Dermatology Clinic · Ipsen · NCT07435428Focused Research On Neurofeedback Therapy In Eradicating Depression (FRONTIER)
Phase 1/Phase 2 · UNB Sumiyoshi Jinja Mae Clinic · UNB Sumiyoshi Jinja Mae Clinic · NCT06557525A Study of Rapcabtagene Autoleucel in Active, Refractory Systemic Lupus Erythematosus (SLE) or Lupus Nephritis (LN) Pati
Phase 2 · Novartis Investigative Site · Novartis Pharmaceuticals · NCT06581198A Study to Investigate Efficacy and Safety of AZD1163 in Participants With Rheumatoid Arthritis
Phase 2 · Research Site · AstraZeneca · NCT07276581Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS
Phase 3 · Kyushu University Hospital · Eli Lilly and Company · NCT06890598A Global Phase III Study of Rilvegostomig or Pembrolizumab Monotherapy for First-Line Treatment of PD-L1-high Metastatic
Phase 3 · Research Site · AstraZeneca · NCT06868277A Study of Eloralintide (LY3841136) in Participants With Obstructive Sleep Apnea and Obesity or Overweight
Phase 3 · Fukuoka University Hospital · Eli Lilly and Company · NCT07369011A Study to Understand How the Study Medicine (PF-06823859) Works in People With Active Idiopathic Inflammatory Myopathie
Phase 3 · Pfizer · NCT05895786A Phase 3, Placebo-Controlled Study to Investigate LP352 in Children and Adults With Dravet Syndrome (DS)
Phase 3 · Fukuoka Children's Hospital · Longboard Pharmaceuticals · NCT06660394
Look up another city
Look up another condition
Eichor
Clinical intelligence from public evidence
Use of Eichor is governed by our Terms of Use · Privacy Policy
© 2026 Biomedistats LLC (dba Eichor)

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.